BC-CfE Interim Recommendations for COVID-19 and Persons with HIV
Recommendations for the prevention, diagnosis, management and treatment of COVID-19 in people with HIV are the same as those for the general population. The available data about the incidence and course of COVID-19 disease in persons with HIV continues to evolve.
Read More
BC-CfE CDET Committee Statement on the use of COVID-19 mRNA vaccines (Pfizer and Moderna) in Persons living with HIV
The BC-CfE’s Committee for Drug Evaluation and Therapy has evaluated the use of Pfizer and Moderna’s COVID-19 mRNA vaccines for Persons Living With HIV. It is the opinion of the CDET that People living with HIV (PWLH) aged 18 years or older may be vaccinated for Covid-19 if they meet current public health criteria for priority groups and if they have no contraindications.
Read More
COVID-19 update and vaccination in PLWHEducation & TrainingRegisterApril 22, 2021
New Educational Webinar:
BC-CfE research on coronavirus evolution helps in vaccine design and deepens understanding of viral mutationsCOVID-19Read more
The BC-CfE Celebrates International Women’s DayInternational Women's DayRead more
March 8th, 2021
BC Centre for Excellence in HIV/AIDS to expand Safer Drug Supply in the DTES with the support of Health Canada's Substance Use and Addictions Program (SUAP)News ReleaseRead more
The BC-CfE mourns the passing of Carl P. Vanderspek, a long-time supporter and champion of the Centre and its causesObituaryRead more
BC Centre for Excellence in HIV/AIDS (BC-CfE) supports the use of Pfizer and Moderna COVID-19 mRNA vaccines for persons living with HIV (PLWH)News ReleaseRead MoreJANUARY 2021
LABORATORYFHS grad students evaluate COVID-19 swab collection techniques to improve patient diagnostic experienceRead More...
